Mankind Pharma Limited — JV/Acquisition, 19-05-2026: Acquisition

Mankind Pharma has acquired the Women's Health Portfolio from its subsidiary, Bharat Serums and Vaccines (BSV), for ₹797 Cr. This strategic move significantly strengthens Mankind's product offerings, enhancing its presence in the growing women's health segment. The acquisition was completed via a slump sale. The financial impact for Mankind includes exceptional items covering stamp duty of ₹19.02 Cr and a ₹13.44 Cr impairment loss from a post-acquisition strategic review related to BSV.